These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2957205)

  • 1. Piroxicam in juvenile rheumatoid arthritis.
    García-Morteo O; Maldonado-Cocco JA; Cuttica R; Garay SM
    Eur J Rheumatol Inflamm; 1987; 8(1):49-53. PubMed ID: 2957205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six-month open safety assessment of a naproxen suspension formulation in the therapy of juvenile rheumatoid arthritis.
    Laxer RM; Silverman ED; St-Cyr C; Tran MT; Lingam G
    Clin Ther; 1988; 10(4):381-7. PubMed ID: 3079006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
    Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Norwegian multicenter study.
    Husby G
    Am J Med; 1986 Nov; 81(5B):6-10. PubMed ID: 3538870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam in acute musculoskeletal disorders and sport injuries.
    Heere LP
    Eur J Rheumatol Inflamm; 1987; 8(1):60-4. PubMed ID: 3305036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen and piroxicam. A comparative trial in rheumatoid arthritis.
    Huskisson EC; Greenwood A
    Eur J Rheumatol Inflamm; 1983; 6(3):242-6. PubMed ID: 6239778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K; Pangerl S
    Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
    Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
    Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diflunisal and piroxicam in the management of patients with rheumatoid arthritis.
    Rice DM
    Clin Ther; 1987; 10(1):92-7. PubMed ID: 3329968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I; Szer IS; Zemel LS; Lovell DJ; Giannini EH; Robbins JL; West CR; Steidle G; Krishnaswami S; Bloom BJ
    J Rheumatol; 2009 Jan; 36(1):174-82. PubMed ID: 19012356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.
    Piñana E; Lei SH; Merino R; Melgosa M; De La Vega R; Gonzales-Obeso E; Ramírez E; Borobia A; Carcas A
    J Clin Pharm Ther; 2010 Jun; 35(3):365-70. PubMed ID: 20831538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis.
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(2):8-12. PubMed ID: 1365474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.
    Schäd SG; Kraus A; Haubitz I; Trcka J; Hamm H; Girschick HJ
    Arthritis Res Ther; 2007; 9(1):R10. PubMed ID: 17266758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study.
    Sydnes OA
    Eur J Rheumatol Inflamm; 1981; 4(3):318-22. PubMed ID: 6242953
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.